Fam-Trastuzumab Deruxtecan (Enhertu) Induced Pyloric Perforation in Hormone Receptor-positive/HER2-low Expresses Metastatic Breast Cancer.

Q1 Medicine

Hematology/ Oncology and Stem Cell Therapy Pub Date : 2023-07-20 DOI:10.56875/2589-0646.1105

Taher Al-Tweigeri

引用次数: 0

查看原文本刊更多论文

fam -曲妥珠单抗德鲁西替康(Enhertu)在激素受体阳性/ her2低表达的转移性乳腺癌中诱导幽门穿孔。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Hematology/ Oncology and Stem Cell Therapy Medicine-Hematology

CiteScore

4.30

自引率

0.00%

发文量

审稿时长

27 weeks

期刊介绍： Hematology Oncology and Stem Cell Therapy is an international, peer-reviewed, open access journal that provides a vehicle for publications of high-quality clinical as well as basic science research reports in hematology and oncology. The contents of the journal also emphasize the growing importance of hematopoietic stem cell therapy for treatment of various benign and malignant hematologic disorders and certain solid tumors.The journal prioritizes publication of original research articles but also would give consideration for brief reports, review articles, special communications, and unique case reports. It also offers a special section for clinically relevant images that provide an important educational value.